Cargando…

Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism

BACKGROUND: Hypogonadism is common among HIV-infected men, even among men receiving antiretroviral therapy (ART). Our objective in this study was to determine the prevalence of biochemical hypogonadism among HIV-infected men compared with HIV-uninfected controls. We also examined the use of free tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monroe, Anne K, Dobs, Adrian S, Palella, Frank J, Kingsley, Lawrence A, Witt, Mallory D, Brown, Todd T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900935/ https://www.ncbi.nlm.nih.gov/pubmed/24450960 http://dx.doi.org/10.1186/1742-6405-11-6

Ejemplares similares

Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: A substudy of the Multicenter AIDS Cohort Study
por: Brown, Todd T, et al.
Publicado: (2009)

Low free testosterone is associated with hypogonadal signs and symptoms in men with normal total testosterone levels: results from the European Male Ageing Study
por: Antonio, Leen, et al.
Publicado: (2015)

SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate
por: Dobs, Adrian Sandra, et al.
Publicado: (2020)

Self-Reported Body Fat Change in HIV-Infected Men Is a Marker of Decline in Physical Health-Related Quality of Life with Aging, Independent of Co-Morbidity
por: Erlandson, Kristine M., et al.
Publicado: (2014)

SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking?
por: Winters, Stephen J.
Publicado: (2020)

Anatomic Fat Depots and Coronary Plaque Among Human Immunodeficiency Virus-Infected and Uninfected Men in the Multicenter AIDS Cohort Study
por: Palella, Frank J., et al.
Publicado: (2016)

SAT-044 Treatment of Hypogonadal Men with a New Oral Testosterone Undecanoate (TU) Formulation Improves Psychosexual, Well-Being and Body Composition and Bone Density Parameters
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

SAT-LB134 Aging Related Changes in Sex Hormone-Binding Globulin in Men With HIV
por: Dias, Jenny Pena, et al.
Publicado: (2020)

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
por: Borst, Stephen E, et al.
Publicado: (2014)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
por: Ide, Veerle, et al.
Publicado: (2020)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
por: DelConte, Anthony, et al.
Publicado: (2022)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
por: Shankara Narayana, Nandini, et al.
Publicado: (2021)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
por: de Almeida Ferreira, Maurício, et al.
Publicado: (2022)

Symptomatic late-onset hypogonadism but normal total testosterone: the importance of testosterone annual decrease velocity
por: La Vignera, Sandro, et al.
Publicado: (2020)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
por: Madhusoodanan, Vinayak, et al.
Publicado: (2019)

Corrigendum for: “A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men”
Publicado: (2020)

Factors Affecting Glomerular Filtration Rate, as Measured by Iohexol Disappearance, in Men with or at Risk for HIV Infection
por: Margolick, Joseph B., et al.
Publicado: (2014)

Sex Hormone–Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men
por: Price, Jennifer C, et al.
Publicado: (2019)

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
por: Yassin, AA, et al.
Publicado: (2013)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
por: Shoskes, Daniel A, et al.
Publicado: (2015)

Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis
por: Elliott, Jesse, et al.
Publicado: (2017)

Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
por: Sachdev, Saachi, et al.
Publicado: (2020)

Effect of Varicocele and Its Treatment on Testosterone in Hypogonadal Men with Varicocele: Review of the Literature
por: Çayan, Selahittin, et al.
Publicado: (2020)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men
por: White, William B., et al.
Publicado: (2021)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

Characteristics and Longitudinal Patterns of Erectile Dysfunction Drug Use Among Men Who Have Sex with Men in the U.S.
por: Park, Jee Won, et al.
Publicado: (2021)

Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015)

OR18-4 Beneficial Effect on Sperm Production of Leflutrozole in Men with Obesity-Associated Secondary Hypogonadotropic Hypogonadism: Results from a Phase II Study
por: Jones, Thomas, et al.
Publicado: (2019)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Nordio, Maurizio, et al.
Publicado: (2021)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Hypogonadotropic hypogonadism in human immunodeficiency virus-infected men: uncommonly low testosterone levels
por: Gomes, Ana Coelho, et al.
Publicado: (2017)

A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men
por: Swerdloff, Ronald S., et al.
Publicado: (2020)

Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ka4bl21b08j410cppf8jc377if